Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

China · Delayed Price · Currency is CNY

19.15

+0.75 (4.08%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Biopharmaceutical	113.23M	80.80M	134.59M	318.49M	392.27M
Biopharmaceutical Growth	40.13%	-39.96%	-57.74%	-18.81%	-33.41%
Total	113.23M	80.80M	134.59M	318.49M	392.27M
Total Growth	40.13%	-39.96%	-57.74%	-18.81%	-33.41%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	113.23M	80.80M	134.59M	318.49M	392.27M
China Growth	40.13%	-39.96%	-57.74%	-18.81%	-33.41%
Total	113.23M	80.80M	134.59M	318.49M	392.27M
Total Growth	40.13%	-39.96%	-57.74%	-18.81%	-33.41%

Source: S&P Global Market Intelligence.